Gestational hypertension
ICD-10 O13 · ICD-11 JA23

Severe Gestational Hypertension: What to Do When First-Line Antihypertensive Therapy Has Not Achieved BP Control

Clinical scenario

De novo hypertension arising at or beyond 20 weeks' gestation — without proteinuria or other features of pre-eclampsia — with severe blood pressure, defined as systolic BP ≥160 mmHg or diastolic BP ≥110 mmHg, in the setting where urgent first-line treatment has not met the required targets.

Why this step is reached

The previous step involved urgent first-line antihypertensive therapy in a monitored setting (agents used: oral nifedipine, oral labetalol, IV labetalol, or IV hydralazine). The required target — systolic BP below 160 mmHg and diastolic BP of 85 mmHg, achieved within one hour — was not reached. This protocol addresses the next clinical step.

Approach at this stage

The strategy involves switching to an antihypertensive agent from a different drug class than the one used initially. The specific agents considered appropriate — including which alternatives apply depending on what was given first, and what constitutes acceptable second-line therapy — are set out in the full protocol.

Complete agent selection, clinical criteria, and sequencing are available in the structured protocol below.
Treatment targets

Lower blood pressure to systolic BP below 160 mmHg and diastolic BP of 85 mmHg.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.preghy.2021.09.008

  1. Hypertension arising de novo at ≥ 20 weeks' gestation in the absence of proteinuria or other findings suggestive of pre-eclampsia.
  2. Severe hypertension in pregnancy (i.e., sBP ≥ 160 mmHg or dBP ≥ 110 mmHg) requires urgent antihypertensive therapy, in a monitored setting (⊕⊕OO/Strong).
  3. If nifedipine or hydralazine were the initial drug used, choose oral labetalol or oral methyldopa as the alternative.
  4. Second-line agents include other beta-blockers, other calcium channel blockers, and prazosin.
  5. If systolic BP (sBP) is ≥160 mmHg, increase dose of existing medication or start new antihypertensive medication to get sBP < 160 mmHg, regardless of diastolic BP.
  6. The target BP for antihypertensive therapy should be a dBP of 85 mmHg, regardless of sBP (⊕⊕⊕⊕/Strong).
View source ↗